Informational

Data use:

We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.

RxOutlook®

The latest pipeline drug information, trend news, upcoming drug launches and emerging therapies in today’s pharmaceutical market.

2nd Quarter 2026

Key topics in this quarter’s edition include:

  • Tryngolza (olezarsen) for treatment of severe hypertriglyceridemia
  • Insulin efsitora alfa for treatment of type 2 diabetes
  • Oveporexton for treatment of narcolepsy
  • Brepocitinib for treatment of dermatomyositis

Download PDF

© 2026 Optum, Inc. All rights reserved. Stock photos used.